161 related articles for article (PubMed ID: 24025357)
1. Prostate cancer progression attributed to autonomic nerve development: potential for therapeutic prevention of localized and metastatic disease.
Fernández EV; Price DK; Figg WD
Cancer Biol Ther; 2013 Nov; 14(11):1005-6. PubMed ID: 24025357
[TBL] [Abstract][Full Text] [Related]
2. Autonomic nerve development contributes to prostate cancer progression.
Bauman J; McVary K
Asian J Androl; 2013 Nov; 15(6):713-4. PubMed ID: 24077601
[TBL] [Abstract][Full Text] [Related]
3. Does the autonomic nervous system contribute to the initiation and progression of prostate cancer?
Ventura S; Evans BA
Asian J Androl; 2013 Nov; 15(6):715-6. PubMed ID: 24141535
[TBL] [Abstract][Full Text] [Related]
4. Autonomic nerve development contributes to prostate cancer progression.
Magnon C; Hall SJ; Lin J; Xue X; Gerber L; Freedland SJ; Frenette PS
Science; 2013 Jul; 341(6142):1236361. PubMed ID: 23846904
[TBL] [Abstract][Full Text] [Related]
5. Words of wisdom: Re: Autonomic nerve development contributes to prostate cancer progression.
Ali A; Pisipati S; Tewari A
Eur Urol; 2014 Mar; 65(3):665-6. PubMed ID: 24484758
[No Abstract] [Full Text] [Related]
6. Cancer. Prostate cancer takes nerve.
Isaacs JT
Science; 2013 Jul; 341(6142):134-5. PubMed ID: 23846894
[No Abstract] [Full Text] [Related]
7. Prostate cancer: a role for neoneurogenesis in tumour progression?
Payton S
Nat Rev Urol; 2013 Sep; 10(9):491. PubMed ID: 23897502
[No Abstract] [Full Text] [Related]
8. Urological cancer: Nerves linked to prostate cancer.
Kirk R
Nat Rev Clin Oncol; 2013 Sep; 10(9):487. PubMed ID: 23897079
[No Abstract] [Full Text] [Related]
9. Tumour microenvironment: Tumours have a lot of nerve.
Seton-Rogers S
Nat Rev Cancer; 2013 Sep; 13(9):608-9. PubMed ID: 23903093
[No Abstract] [Full Text] [Related]
10. Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression.
White CW; Xie JH; Ventura S
Organogenesis; 2013; 9(3):206-15. PubMed ID: 23872639
[TBL] [Abstract][Full Text] [Related]
11. Tumour innervation and neurosignalling in prostate cancer.
March B; Faulkner S; Jobling P; Steigler A; Blatt A; Denham J; Hondermarck H
Nat Rev Urol; 2020 Feb; 17(2):119-130. PubMed ID: 31937919
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer.
Reeves FA; Battye S; Roth H; Peters JS; Hovens C; Costello AJ; Corcoran NM
J Clin Neurosci; 2019 May; 63():213-219. PubMed ID: 30772200
[TBL] [Abstract][Full Text] [Related]
14. β
Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
16. Burned-out Prostate Cancer ? Primary Metastatic Cancer Not Detected on Repeat Biopsy.
Mitsui Y; Sadahira T; Maruyama Y; Wada K; Tanimoto R; Sugimoto M; Araki M; Watanabe M; Yanai H; Watanabe T; Nasu Y
Acta Med Okayama; 2018 Dec; 72(6):605-609. PubMed ID: 30573917
[TBL] [Abstract][Full Text] [Related]
17. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
18. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic and parasympathetic innervation in hepatocellular carcinoma.
Zhang L; Wu LL; Huan HB; Chen XJ; Wen XD; Yang DP; Xia F
Neoplasma; 2017; 64(6):840-846. PubMed ID: 28895408
[TBL] [Abstract][Full Text] [Related]
20. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
